简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2013-10-08 15:25 KCI, LifeCell and Systagenix to Form One Company Focused on Transformational Healing Solutions under the Leadership of President & CEO Joe Woody
2013-10-08 14:50 TranScrip Partners Announce Hong Kong Expansion
2013-09-27 10:41 Dynex Technologies Receives SFDA Approval to Supply DSX Automated ELISA Processing System to China
2013-09-26 15:19 electroCore Strengthens Its Global Management Team
2013-09-26 15:13 Valimo Mobile ID enables mobile identity based secure login for national health service in Finland
2013-09-25 18:06 Quintiles Advances New Approach to Speed Biomarker-Targeted Therapies to Cancer Patients
2013-09-25 17:01 Robert Weinberg, Leroy Hood, Bob Löwenberg, Olli Kallioniemi, Rene Bernards, Guido Kroemer, Hans Clevers, Matthias Uhlen and Other Top Experts in Tumor Biology and Precision Cancer Medicine to Present at WIN 2014 Symposium
2013-09-23 18:00 Oral-B® Announces Launch of New Digital Tool for Better Oral Care
2013-09-23 14:40 Executive Director of US Authors Guild Has ALS; Says Early-Stage Symptoms Are in Remission with Steroid Treatments.
2013-09-23 11:12 Lengthy Neurological Diagnosis Delay May Impact Patients, Survey Shows
2013-09-17 16:40 Gemalto Delivers Secure eHealthcare Solution to Hospital in US
2013-09-17 12:21 Quintiles Completes Acquisition of Novella Clinical
2013-09-13 11:51 WIN2014 Symposium June 23-24, First Announcement: “WINning Combinations for Precision Cancer Medicine”
2013-09-10 16:14 Quintiles Named to InformationWeek 500 for Fifth Consecutive Year
2013-09-10 08:00 DRI Capital Raises U.S. $1.45 Billion for Drug Royalty III
2013-09-09 18:35 22nd Century Group Announces Allowance of U.S. Patent for Regulating Nicotine in Tobacco with Transcription Factor Gene
2013-09-06 10:00 Otsuka Pharmaceutical to Acquire Astex Pharmaceuticals
2013-09-05 11:44 IRI Acquires Market Leader Aztec and Gains Significant, Complementary Footprint in Important Geographies
2013-09-04 12:15 WIN Consortium Receives 3 Million Euro EU FP7 Grant to Conduct WINTHER, WIN’s First Cancer Personalized Medicine Clinical Trial
2013-09-03 17:42 IntegenX to Present Significant Advances in Rapid DNA Technology at the 25th World Congress of the International Society of Forensic Genetics (ISFG)

Business Wire Weibo

Press Releases

Latest Releases